GeneDx Presents New Data at ACMG Demonstrating the Benefits of Exome Sequencing Over Chromosomal Microarray
March 16, 2023 08:45 ET
|
GeneDx Holdings Corp.
STAMFORD, Conn., March 16, 2023 (GLOBE NEWSWIRE) -- GeneDx Holdings Corp. (GeneDx) (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, announced new...
GeneDx honors Rare Disease Day and announces presentations and research at the 2023 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
February 28, 2023 08:30 ET
|
GeneDx Holdings Corp.
STAMFORD, Conn., Feb. 28, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced its contributions to...
Gene Synthesis Global Market Report 2023: Advent of Enzymatic DNA Synthesis Process Boosts Growth
February 16, 2023 08:48 ET
|
Research and Markets
Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Gene Synthesis Market Size, Share & Trends Analysis Report By Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By...
GeneDx Rare Disease Data Demonstrates Utility in Drug Candidate Identification for Common Diseases
February 16, 2023 08:30 ET
|
GeneDx Holdings Corp.
STAMFORD, Conn., Feb. 16, 2023 (GLOBE NEWSWIRE) -- GeneDx Holdings Corp. (GeneDx) (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, continues to...
NGS Library Preparation Global Market Report 2023: Declining Costs of Sequencing Drives Growth
February 14, 2023 06:18 ET
|
Research and Markets
Dublin, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The "NGS Library Preparation Market By Product (Kits, Reagents, Instruments), Sequencing Type (Genome, Exome, Targeted), Application (Diagnostics,...
Advances in Gene Editing Technologies in Healthcare, 2023 Research Report - Next-Generation Genome Editing Tools and Improved Delivery Are Bolstering Gene Editing Therapeutics and Diagnostics
February 10, 2023 10:53 ET
|
Research and Markets
Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Advances in Gene Editing Technologies in Healthcare" report has been added to ResearchAndMarkets.com's offering. CRISPR, ZFNs, and TALENs are...
Whole Genome and Exome Sequencing Markets Report 2023-2027: Industry on Verge of Breakout in Healthcare, Consumer and Agricultural Markets
February 08, 2023 03:08 ET
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer...
GeneDx Makes Significant Industry-Wide Contributions to New Disease Gene Discovery
January 30, 2023 08:30 ET
|
GeneDx Holdings Corp.
Company submitted nearly one quarter of all candidate gene submissions to GeneMatcher in 2022 and collaborated on 63 publications involving new disease-gene associations or expansion of phenotype...
CRISPR Technology Global Markets Report 2023: A $9.2 Billion Market by 2027, from $3.3 Billion in 2022
January 25, 2023 04:08 ET
|
Research and Markets
Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The "CRISPR Technology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report provides detailed exposure to the...
Global Genomics Market Forecasts Report 2023-2027 - Increasing Demand of Specialized/Personalized Medicine Fueling Demand
January 19, 2023 05:58 ET
|
Research and Markets
Dublin, Jan. 19, 2023 (GLOBE NEWSWIRE) -- The "Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Products & Services (Systems &...